These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30535775)

  • 1. Overexpression of SMN2 Gene in Motoneuron-Like Cells Differentiated from Adipose-Derived Mesenchymal Stem Cells by Ponasterone A.
    Mohseni R; Ashrafi MR; Ai J; Nikougoftar M; Mohammadi M; Ghahvechi-Akbari M; Shoae-Hassani A; Hamidieh AA
    J Mol Neurosci; 2019 Feb; 67(2):247-257. PubMed ID: 30535775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New methods for inducing the differentiation of amniotic-derived mesenchymal stem cells into motor neuron precursor cells.
    Hu W; Guan FX; Li Y; Tang YJ; Yang F; Yang B
    Tissue Cell; 2013 Oct; 45(5):295-305. PubMed ID: 23806299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the differential phenotypes of spinal muscular atrophy with high-yield generation of motor neurons from human induced pluripotent stem cells.
    Lin X; Li JJ; Qian WJ; Zhang QJ; Wang ZF; Lu YQ; Dong EL; He J; Wang N; Ma LX; Chen WJ
    Oncotarget; 2017 Jun; 8(26):42030-42042. PubMed ID: 28159932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Motor Neuron-Like Cells from Tonsil-Derived Mesenchymal Stem Cells and Their Possible Application to Neuromuscular Junction Formation.
    Park S; Kim JY; Myung S; Jung N; Choi Y; Jung SC
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches.
    Nizzardo M; Simone C; Dametti S; Salani S; Ulzi G; Pagliarani S; Rizzo F; Frattini E; Pagani F; Bresolin N; Comi G; Corti S
    Sci Rep; 2015 Jun; 5():11746. PubMed ID: 26123042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
    Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
    Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate.
    Garbes L; Riessland M; Hölker I; Heller R; Hauke J; Tränkle C; Coras R; Blümcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2009 Oct; 18(19):3645-58. PubMed ID: 19584083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells.
    Chen YC; Chang JG; Liu TY; Jong YJ; Cheng WL; Yuo CY
    Biomed Pharmacother; 2017 Apr; 88():708-714. PubMed ID: 28152480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
    Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
    Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro.
    Liqing Y; Jia G; Jiqing C; Ran G; Fei C; Jie K; Yanyun W; Cheng Z
    Neuroreport; 2011 Jun; 22(8):370-3. PubMed ID: 21532392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
    Seo J; Singh NN; Ottesen EW; Sivanesan S; Shishimorova M; Singh RN
    PLoS One; 2016; 11(4):e0154390. PubMed ID: 27111068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells.
    Park HW; Cho JS; Park CK; Jung SJ; Park CH; Lee SJ; Oh SB; Park YS; Chang MS
    PLoS One; 2012; 7(4):e35244. PubMed ID: 22496912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of flavonoid quercetin on survival of motor neuron gene expression.
    Uzunallı G; Bora-Tatar G; Dayangaç-Erden D; Erdem-Yurter H
    Cell Biol Int; 2015 Mar; 39(3):350-4. PubMed ID: 25319353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The water extract of Liuwei dihuang possesses multi-protective properties on neurons and muscle tissue against deficiency of survival motor neuron protein.
    Tseng YT; Jong YJ; Liang WF; Chang FR; Lo YC
    Phytomedicine; 2017 Oct; 34():97-105. PubMed ID: 28899515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOCS7-Derived BC-Box Motif Peptide Mediated Cholinergic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.
    Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Shinonaga M; Kubo A; Fujii S; Ishizuka Y; Tanaka M; Ichihashi M; Murata H
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation.
    Farooq F; Abadía-Molina F; MacKenzie D; Hadwen J; Shamim F; O'Reilly S; Holcik M; MacKenzie A
    Hum Mol Genet; 2013 Sep; 22(17):3415-24. PubMed ID: 23656793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.